Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Syndax Pharmaceuticals

Biotech & Life Sciences · Waltham, United States · Founded 2005 · IPO 2016 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.75B
Market cap · Apr/2026
Revenue
$277M
Latest reported FY

Investors

17 investors on Syndax Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage
MPM BioImpact
Domain Associates
Series B+ 15 investors entered at this stage
Cormorant Asset Management
Avalon Ventures
Aisling Capital
OrbiMed
BioMed Ventures
Fidelity Investments
Delos Capital
EcoR1 Capital
Foresite Capital
RMI Partners
Forward Ventures
ArrowMark Partners
Jennison Associates
Stanford University
SRI International

Global footprint

Where Syndax Pharmaceuticals has talent and traffic

Web traffic by country
17K monthly visits
across markets
🇺🇸 United States62.9%
🇨🇦 Canada11.2%
🇬🇧 United Kingdom9.4%
🇮🇳 India7.1%
🇫🇷 France4.7%
Top 5 markets shown

See Syndax Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo